Why intellectual property rights are a key, not a curse, for Covid-19 vaccines
31 January 2021 - 16:08
The rapid development of new Covid-19 vaccines and treatments over the past year is a triumph of innovation. Billions of vaccine doses are being manufactured and should be distributed to all adults globally over the next 18 months.
But health non-governmental organisations (NGOs) and some governments argue that suspending intellectual property (IP) rights to allow unfettered vaccine manufacture will mean faster access for developing countries...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.